Reconsidering Adjuvant Immunotherapy for Tuberculosis
Year: 2005
Type: review
Source: Clinical Infectious Diseases
DOI: 10.1086/430914
Author: Robert S. Wallis
Institution: Pharmaceutical Product Development (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, Louisiana State University
OpenAlex ID: W2133199321
